ASH 2016: Dr. Matt Davids of the Combination of TGR-1202 and Ibrutinib for Relapsed Refractory CLL (chronic Lymphocytic Leukemia)

This week, on the CLL Society website we are sharing a video interview with Dr. Matthew Davids from  ASH 2016 where we discuss a clinical trial that combines two targeted therapies for treating relapsed/refractory CLL, ibrutinib and TGR-1202. You can read the summary and watch the video or read the transcript here
TOMORROW, we'll be publishing the first 2017 issue of The CLL Tribune and marking the 2 year anniversary since our website went live! Watch for it!
Two years. WOW!CLL Patient Support Group Meetings This Week
Monday, April 3rd at 6 PM in Indianapolis - the CLL and Indolent Blood Cancers Support Group will be meeting. More information here.
Tuesday, April 4th at 7 PM in Tucker, GA - the Tucker Family Support Group, sponsored by the Leukemia and Lymphoma Society will be meeting.  More information here.   NEW CLL Patient Support Group Meetings Coming Up
Saturday, April 15th at 3 PM in Vienna, VA - the Washington DC-Area CLL Support Group, sponsored by the CLL Society will be meeting for the first time. More information here.
Saturday, April 22nd at 1 PM in the Boston area -the Boston CLL Support Group, sponsored by the CLL Society will be meeting for the first time. More information here. 
Sunday, April 23rd at 4 PM in San Francisco - the San Francisco CLL Support Group, sponsored by the CLL Society will be meeting for the first time. More information here. ALSO - We are actively forming CLL-specific support group in a number of cities around the country. To see if your city is one of them, go to our home page  and click on the interest survey for your city. JUST ADDED - Rochester, NY; Milwaukee, WI; Atlanta, GA; Salt Lake City, UT; Huntsville, AL. Not listed, but interested in starting one? Email us at support@cllsociety.org. Thanks!
Upcoming Patient Education Meetings

• Saturday, April 1st from 7:30 AM to 3:00 PM in Atlanta, GA: The Lymphoma Research Foundation will be hosting Lymphoma Workshop: Understanding Lymphoma Basics and Current Treatment Options which will include disease-specific breakout sessions. There is no cost to attend, but registration is required. Find out more information here. ALSO Rick Conner, a CLL patient in the Atlanta area will be manning the CLL Society table and collecting names of those who might be interested in a CLL-specific patient support group. Stop by and say Hello!
• Thursday, April 6th from 6:00 PM to 8:30 PM in Boston, MA: The Lymphoma Research Foundation will be hosting Ask the Doctor: Updates on CLL/SLL. There is no cost to attend, but registration is required. Dinner will be provided for registered attendees. Find out more information here.
• Thursday, April 20th from 6:00 PM to 8:30 PM in Cherry Hill, NJ: Anthony Mato, MD, MSCE from the Abramson Cancer Center in Philadelphia will be chairing the patient educational forum, CLL in 2017: State of the Art Management from a Patient's Perspective with his team. Brian Koffman, MD from the CLL Society will also be speaking. There is no cost to attend, but registration is required. Attendance is limited and registration will be closed when attendance limits are reached. Dinner will be provided for registered attendees. Find out more information here.
• Monday, April 24th in Columbus, OH and streaming live: Ask the Expert: Nutrition & Chronic Lymphocytic Leukemia will be held at The James at Ohio State University. This event is free, but pre-registration is required. Visit https://nutritionandcll.eventbrite.com  to register or for more information, please call JamesCare for Life at 614-293-6428. Find out more information here. 

In the meantime....
Stay strong.
We are all in this together.
Brian Koffman, MDMarch 28, 2017
http://cllsociety.org
If you want a personal response, or just want to stay in touch, please email me at bkoffmanMD@gmail.com. I have no other way of contacting. Thanks. Stay strong. After all, we are all in this together. And please visit our website: http://cllsociety.org for the latest news and information.